Correlation Between Enlivex Therapeutics and Multicell Techs

Can any of the company-specific risk be diversified away by investing in both Enlivex Therapeutics and Multicell Techs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enlivex Therapeutics and Multicell Techs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Enlivex Therapeutics and Multicell Techs, you can compare the effects of market volatilities on Enlivex Therapeutics and Multicell Techs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enlivex Therapeutics with a short position of Multicell Techs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enlivex Therapeutics and Multicell Techs.

Diversification Opportunities for Enlivex Therapeutics and Multicell Techs

0.0

Correlation Coefficient

Enlivex Therapeutics  Multicell Techs

Pay attention - limited upside

The 3 months correlation between Enlivex and Multicell is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Enlivex Therapeutics and Multicell Techs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Multicell Techs and Enlivex Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enlivex Therapeutics are associated (or correlated) with Multicell Techs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Multicell Techs has no effect on the direction of Enlivex Therapeutics i.e., Enlivex Therapeutics and Multicell Techs go up and down completely randomly.

Pair Corralation between Enlivex Therapeutics and Multicell Techs

Given the investment horizon of 90 days Enlivex Therapeutics is expected to generate 1.21 times more return on investment than Multicell Techs. However, Enlivex Therapeutics is 1.21 times more volatile than Multicell Techs. It trades about 0.0 of its potential returns per unit of risk. Multicell Techs is currently generating about -0.06 per unit of risk. If you would invest  253.00  in Enlivex Therapeutics on September 12, 2024 and sell it today you would lose (128.00) from holding Enlivex Therapeutics or give up 50.59% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.7%
Values	Daily Returns

Enlivex Therapeutics  vs.  Multicell Techs

Enlivex Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Enlivex Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Multicell Techs

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Multicell Techs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Multicell Techs is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Enlivex Therapeutics and Multicell Techs

The main advantage of trading using opposite Enlivex Therapeutics and Multicell Techs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enlivex Therapeutics position performs unexpectedly, Multicell Techs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Multicell Techs will offset losses from the drop in Multicell Techs' long position.

The idea behind Enlivex Therapeutics and Multicell Techs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.